Skip to main content
Clinical Trials/NCT02699229
NCT02699229
Withdrawn
Not Applicable

Non-linear Multimodal Microendoscopy for Lung Cancer Pathology

University Health Network, Toronto0 sitesJanuary 11, 2024
ConditionsLung Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
University Health Network, Toronto
Primary Endpoint
Nonlinear optical microscopy for cancerous tissue detection in human lung lesions
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

For this study the investigators are looking to do the following:

  1. To characterize human lung lesions by nonlinear microscopy using ex vivo tissues.
  2. To establish the first spectral/structural database for nonlinear optical microimaging of normal and abnormal lung tissue.

Detailed Description

For this study the investigators are looking to do the following: 1. To characterize human lung lesions by nonlinear microscopy using ex vivo tissues. In particular, to investigate collagen content and ultrastructure with SHG (second harmonic generation) microscopy, to characterize cell and nuclear morphology and lipid vesicle content with THG (third harmonic generation) and CARS (coherent anti-Stokes Raman scattering) microscopy and to conduct spectroscopic and lifetime characterization of MPF (multiphoton fluorescence) signals in cancerous, benign, and normal tissues. 2. To establish the first spectral/structural database for nonlinear optical microimaging of normal and abnormal lung tissue, from which to generate diagnostic algorithms, both to optimize the operating parameters of planned nonlinear endoscopic imaging and to serve as the basis for nonlinear optical histopathology.

Registry
clinicaltrials.gov
Start Date
January 11, 2024
End Date
December 3, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older.
  • Patients with confirmed or suspected lung cancer who require lobectomy as part of standard-of-care.

Exclusion Criteria

  • Patients deemed on clinical grounds not to be medically fit for a lobectomy
  • Patients where there is a high clinical suspicion of lymphoma (to avoid mixing the data sets).
  • Patients unable to give informed consent

Outcomes

Primary Outcomes

Nonlinear optical microscopy for cancerous tissue detection in human lung lesions

Time Frame: Two years

Secondary Outcomes

  • The first spectral/structural database for nonlinear optical micro-imaging of normal and abnormal lung tissue(Two Years)

Similar Trials